EFM
CGON icon

E Fund Management’s CG Oncology CGON Stock Holding History

E Fund Management’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$594K Buy
+8,779
New +$497K 0.02% 251
2025
Q2 		$232K Buy
+8,932
New +$215K 0.01% 345

Other funds holding CGON

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

E Fund Management's CGON Position: Q1 2026 in Review

E Fund Management opened a new position in CG Oncology (CGON) in Q1 2026: 8,779 shares worth $594K. The stake represents 0.02% of the portfolio and ranks #251 among its holdings. This is a return to the name: E Fund Management previously reported a position in CGON as recently as Q2 2025.

E Fund Management first reported a position in CGON in Q2 2025 and has held it in 2 quarters since. 233 funds tracked by Wall St. Rank hold CGON as of Q1 2026.

  • E Fund Management held 8,779 shares of CG Oncology worth $594K as of Q1 2026.
  • CG Oncology was a new E Fund Management position in Q1 2026.
  • CG Oncology made up 0.02% of E Fund Management's portfolio in Q1 2026, its #251 holding.
  • E Fund Management first reported a position in CG Oncology in Q2 2025 and has held it in 2 quarters since.
  • 233 funds tracked by Wall St. Rank held CG Oncology as of Q1 2026.

Based on E Fund Management's 13F filing for Q1 2026, filed 13 Apr 2026.